lilly oral glp-1 Eli Lilly's New Orforglipron Beats Semaglutide In Diabetes Trials; FDA Filing Near Lilly's GLP-1 pill outperforms Novo's

Medicares search for effective obesity treatments: diets are not the answer

In animal research, MSM has been shown to reduce cartilage degradation and joint inflammation in rodent models of osteoarthritis, likely through both anti-inflammatory and antioxidant mechanisms (Usha & Naidu, 2004

The CYP2C9 inhibition discussed above makes this combination genuinely risky

Aichler M, Borgmann D, Krumsiek J, Buck A, MacDonald PE, Fox JEM, et al

Providers use this information to decide whether GLP-1 treatment is appropriate and which medication may be the best fit

Outside the US it is supplied as a research-grade peptide and is not approved for human use by any major regulator